Definitive Contract 75D30120C08325
Award Date 6/12/20
Potential Completion Date 1/31/24
Potential Value $2.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Seattle, WA 98105, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
100
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $5,092,787.07 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The contract is for COVID-19 research focused on critically ill children and does not have a set-aside designation. Boston Children's Hospital is a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical School. Through this contract, the hospital is...
- This is a $100,000.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract does not have a set-aside designation. The contract supports data collection on consumer product-related injuries, studies on respiratory viral transmission in K-12 schools, epidemiological research on symptomatic and asymptomatic...
- This is a $6,157,849.35 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract is for a Broad Agency Announcement (BAA) research effort focused on the epidemiology of symptomatic and asymptomatic respiratory viruses, as well as the evaluation of COVID-19 and influenza vaccine effectiveness in K-12 populations. The contract does...
- This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation. Under the contract, Fred Hutchinson Cancer Center is...
- This is a $31,468,032.25 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, titled "FLUMED FOR OTHER FUNCTIONS," has a firm fixed-price pricing arrangement and an ultimate completion date of January 30, 2023. The contract does not have a set-aside designation. Through this award, Boston...
- This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, for the Structural Genomics Centers for Infectious Diseases program. The contract has a potential value of $25,252,157.23 and runs from September 1, 2017 through August 31, 2022. It is a cost plus fixed fee definitive contract with no...
- The University of Washington was awarded a $1,256,015.00 federal contract by the Centers for Disease Control and Prevention (CDC) to conduct a prospective observational cohort study of household transmission of COVID-19 in Seattle, Washington. This definitive cost-type contract has a completion date of January 1, 2022 and does not have a set-aside designation. Through this contract, the University of Washington will provide research services to the CDC to investigate the spread of COVID-19...
- This is a $9,730,025.00 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, which does not have a set-aside designation, is for a scientific study with an ultimate completion date of February 22, 2028. Boston Children's Hospital, an institution affiliated with Harvard Medical School, has...
- This is a cost-no-fee delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Children's Hospital Medical Center, a non-profit hospital and research institution located in Cincinnati, Ohio. The contract is part of the Clinical Immunization Safety Assessment (CISA) master indefinite-delivery, indefinite-quantity (IDIQ) contract and has a ceiling value of $697,191.00. The order requires Children's Hospital Medical Center to provide services related to COVID-19 pediatric...
- This is a definitive federal contract award made by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) to conduct a prospective observational cohort study characterizing the burden of COVID-19. The contract has a ceiling value of $1,093,591.76 and a completion date of December 31, 2021. The contract was awarded on September 3, 2020 and does not have a set-aside designation. As a leading research institution, UW has extensive experience providing research...